This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Eotvos Lorand Tudomanyegyetem, Printnet Kereskedelmi És Szolgáltató Kft.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Mihály Kovács: Innovator in Pharmaceutical Compounds
Introduction
Mihály Kovács is a notable inventor hailing from Kecskemét, Hungary. With a focus on advancing pharmaceutical science, he holds two significant patents that contribute to the understanding and treatment of medical conditions.
Latest Patents
Kovács’ latest patents revolve around "Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms." These patents detail compounds that include various forms such as salts, solvates, tautomers, stereoisomers, and mixtures, all aimed at offering significant pharmaceutical applications. His inventions are poised to play a vital role in the development of therapies that target specific myosin 2 isoforms.
Career Highlights
Throughout his career, Kovács has collaborated with prominent institutions, including Eötvös Loránd University. His work here underscores his commitment to advancing educational and research initiatives that further scientific understanding. Additionally, he has been affiliated with Printnet Kereskedelmi és Szolgáltató Kft., where his innovative endeavors have been instrumental in various projects.
Collaborations
Mihály Kovács has worked alongside esteemed colleagues such as András Málnási-Csizmadia and András Szabó. Their collaborations have enriched the research landscape and enhanced the development of groundbreaking pharmaceutical compounds.
Conclusion
Mihály Kovács stands out as a significant figure in the realm of pharmaceuticals, with his inventions paving the way for future advancements in medical treatments. His dedication to innovation and collaboration demonstrates a profound commitment to improving health outcomes through science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile